Zelmac Chiesa News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Zelmac Chiesa. Real-time updates on events, politics, business and more.

Nektar Therapeutics Announces Phase 1b Data for Novel T Regulatory Cell Stimulator NKTR-358 (LY3471851) in Patients with Atopic Dermatitis

December 15, 2021

/PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today announced that its partner Eli Lilly & Company presented preliminary results from a Lilly-sponsored...

United States Andhra Pradesh San Francisco Dan Budwick Zelmac Chiesa Vivian Wu

Source: prnewswire.com

Nektar Therapeutics Announces Phase 1b Data for Novel T Regulatory Cell Stimulator NKTR-358 (LY3471851) in Patients with Atopic Dermatitis

December 15, 2021

/PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today announced that its partner Eli Lilly & Company presented preliminary results from a Lilly-sponsored...

United States Andhra Pradesh San Francisco Dan Budwick Zelmac Chiesa Vivian Wu

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Zelmac Chiesa News Today

Nektar Therapeutics Announces Phase 1b Data for Novel T Regulatory Cell Stimulator NKTR-358 (LY3471851) in Patients with Atopic Dermatitis

Nektar Therapeutics Announces Phase 1b Data for Novel T Regulatory Cell Stimulator NKTR-358 (LY3471851) in Patients with Atopic Dermatitis

Explore More Categories